Elisabetta Parisi
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
Papers
2
Total Citations
67
H-Index
2
About
Dr. Elisabetta Parisi is a leading head and neck surgical oncologist whose work has significantly advanced the management of oropharyngeal cancers. Her primary research focuses on the comparative effectiveness of trans-oral robotic surgery (TORS) versus definitive chemoradiotherapy, a critical debate in modern oncology. In her landmark 2020 study, she provided a comprehensive 10-year institutional analysis, demonstrating that TORS offers comparable oncologic outcomes with potentially reduced long-term toxicity, a finding that has directly influenced clinical decision-making and garnered 35 citations. Dr. Parisi further revolutionized the field with her 2019 meta-analysis on the role of TORS in identifying primary tumor sites in patients with head-neck unknown primary cancers. This work, cited 32 times, established TORS as a powerful diagnostic tool, sparing many patients from unnecessary, extensive treatments. Her contributions have not only refined surgical approaches but also improved quality of life for countless individuals. Dr. Parisi’s research continues to shape the future of head and neck cancer care, bridging the gap between surgical innovation and patient-centered outcomes.
Research Focus
Key Achievements
Top Papers
- 1
- 2